Walleye Capital’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.45M Sell
193,882
-192,301
-50% -$7.26M 0.01% 1511
2026
Q2
$14.4M Buy
+386,183
New +$11.8M 0.05% 344
2026
Q1
– Sell
-42,976
Closed -$1.49M – 4659
2025
Q4
$1.49M Sell
42,976
-37,948
-47% -$1.21M ﹤0.01% 2110
2025
Q3
$2.2M Buy
80,924
+62,989
+351% +$1.52M 0.01% 1497
2025
Q2
$377K Sell
17,935
-39,706
-69% -$762K ﹤0.01% 2878
2025
Q1
$944K Buy
57,641
+36,329
+170% +$774K ﹤0.01% 2018
2024
Q4
$548K Sell
21,312
-119,859
-85% -$3.39M ﹤0.01% 2907
2024
Q3
$4.47M Buy
141,171
+127,800
+956% +$4.85M 0.01% 1256
2024
Q2
$469K Sell
13,371
-100,666
-88% -$3.99M ﹤0.01% 3565
2024
Q1
$5M Sell
114,037
-85,854
-43% -$3.69M 0.01% 1296
2023
Q4
$7.11M Buy
199,891
+115,928
+138% +$3.46M 0.02% 874
2023
Q3
$2.27M Buy
+83,963
New +$2.13M 0.01% 1632

Other funds holding IDYA

Walleye Capital's IDYA Position: Q3 2026 in Review

Walleye Capital reduced its IDEAYA Biosciences (IDYA) stake by 50% in Q3 2026, selling an estimated $7.26M and leaving 193,882 shares worth $7.45M. The position accounts for 0.01% of the portfolio, ranked #1511.

Walleye Capital first reported a position in IDYA in Q3 2023 and has held it in 12 quarters since. The position peaked at $14.4M in Q2 2026. 279 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Walleye Capital held 193,882 shares of IDEAYA Biosciences worth $7.45M as of Q3 2026.
  • Walleye Capital sold 192,301 IDEAYA Biosciences shares in Q3 2026, an estimated $7.26M.
  • IDEAYA Biosciences made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1511 holding.
  • Walleye Capital first reported a position in IDEAYA Biosciences in Q3 2023 and has held it in 12 quarters since.
  • Walleye Capital's IDEAYA Biosciences position peaked at $14.4M in Q2 2026.
  • 279 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.